{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:59:33Z","timestamp":1783483173481,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","earlyhumandevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Early Human Development"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.earlhumdev.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,7,13]],"date-time":"2016-07-13T23:56:41Z","timestamp":1468454201000},"page":"73-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pregnancy outcomes after fetal exposure to antithyroid medications or levothyroxine"],"prefix":"10.1016","volume":"101","author":[{"given":"Lene","family":"Schurmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Vinkel","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Garne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.earlhumdev.2016.06.006_bb0005","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J. Clin. Metab."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0010","series-title":"Cochrane Database of Systematic Reviews","article-title":"Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy","author":"Reid","year":"2013"},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0015","series-title":"Cochrane Database of Systematic Reviews","article-title":"Interventions for hyperthyroidism pre-pregnancy and during pregnancy","author":"Earl","year":"2013"},{"issue":"4","key":"10.1016\/j.earlhumdev.2016.06.006_bb0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14310\/horm.2002.1379","article-title":"Prediction of maternal and neonatal adverse outcomes in pregnant women treated for hypothyroidism","volume":"11","author":"Poulasouchidou","year":"2012","journal-title":"Hormones"},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0025","first-page":"135","article-title":"Low birth weight in children born to mothers with hyperthyroidism and high birth weight in hypothyroidism, whereas preterm birth is common in both conditions: a Danish national hospital register study","volume":"2","author":"Andersen","year":"2013","journal-title":"Eur. Thryoid J."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0030","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Antithyroid drug use in early pregnancy and birth defects: time window of relative safety and high risk?","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0035","first-page":"S2","article-title":"The EUROCAT network \u2013 organization and processes. Birth defects research (part a): clinical and molecular","volume":"91","author":"Boyd","year":"2011","journal-title":"Teratology"},{"issue":"Number 6","key":"10.1016\/j.earlhumdev.2016.06.006_bb0040","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"Korelits","year":"2013","journal-title":"Thyroid"},{"issue":"Number X","key":"10.1016\/j.earlhumdev.2016.06.006_bb0045","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"X","author":"Andersen","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.earlhumdev.2016.06.006_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2009.03495.x","article-title":"Pregnancy outcome, thyroid dysfunction and fetal goiter after in utero exposure to propylthiouracil: a controlled cohort study","volume":"68","author":"Rosenfeld","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0060","first-page":"232","article-title":"Maternal hypothyroidism may affect fetal growth and neonatal thyroid function","volume":"102","author":"Blazer","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0065","doi-asserted-by":"crossref","first-page":"d2616","DOI":"10.1136\/bmj.d2616","article-title":"Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence","volume":"342","author":"Thangaratinam","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-14-0524","article-title":"Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole\/carbimazole embryopathy","author":"Andersen","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0075","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0080","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformations","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.earlhumdev.2016.06.006_bb0085","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1210\/jc.2013-3549","article-title":"Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices","volume":"98","author":"Rivkees","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.earlhumdev.2016.06.006_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CLEP.S94394","article-title":"Positive predictive value and completeness of prenatally assigned International Classification of Disease-10 kidney anomaly diagnoses in the Danish National Patient Registry","volume":"8","author":"Ramussen","year":"2016","journal-title":"Clin. Epidemiol."}],"container-title":["Early Human Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378215300463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378378215300463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T11:30:36Z","timestamp":1536579036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378378215300463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":18,"alternative-id":["S0378378215300463"],"URL":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2016.06.006","relation":{},"ISSN":["0378-3782"],"issn-type":[{"value":"0378-3782","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes after fetal exposure to antithyroid medications or levothyroxine","name":"articletitle","label":"Article Title"},{"value":"Early Human Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.earlhumdev.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}